These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 23375861)
1. Study of fungal isolates in patients with chronic diarrhea at a tertiary care hospital in north India. Banerjee P; Kaur R; Uppal B J Mycol Med; 2013 Mar; 23(1):21-6. PubMed ID: 23375861 [TBL] [Abstract][Full Text] [Related]
2. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria. Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703 [TBL] [Abstract][Full Text] [Related]
3. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains. Panizo MM; Reviákina V; Dolande M; Selgrad S Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550 [TBL] [Abstract][Full Text] [Related]
6. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)]. Durán MT; Velasco D; Canle D; Moure R; Villanueva R Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381 [TBL] [Abstract][Full Text] [Related]
7. Species distribution and drug susceptibility of candida in clinical isolates from a tertiary care centre at Indore. Pahwa N; Kumar R; Nirkhiwale S; Bandi A Indian J Med Microbiol; 2014; 32(1):44-8. PubMed ID: 24399387 [TBL] [Abstract][Full Text] [Related]
8. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran. Razzaghi-Abyaneh M; Sadeghi G; Zeinali E; Alirezaee M; Shams-Ghahfarokhi M; Amani A; Mirahmadi R; Tolouei R J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256 [TBL] [Abstract][Full Text] [Related]
9. Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candida species. Pereira GH; Müller PR; Szeszs MW; Levin AS; Melhem MS Med Mycol; 2010 Sep; 48(6):839-42. PubMed ID: 20163281 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G; J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005. Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683 [TBL] [Abstract][Full Text] [Related]
12. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species]. Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972 [TBL] [Abstract][Full Text] [Related]
13. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey. Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of candidemia in a Turkish tertiary care hospital. Bakir M; Cerikcioglu N; Barton R; Yagci A APMIS; 2006 Sep; 114(9):601-10. PubMed ID: 16948812 [TBL] [Abstract][Full Text] [Related]
15. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study. Schmalreck AF; Willinger B; Haase G; Blum G; Lass-Flörl C; Fegeler W; Becker K; Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267 [TBL] [Abstract][Full Text] [Related]
16. Antifungal drug resistance in pathogenic fungi. Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500 [TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil. Almeida AA; Mesquita CS; Svidzinski TI; Oliveira KM Rev Soc Bras Med Trop; 2013; 46(3):335-9. PubMed ID: 23856873 [TBL] [Abstract][Full Text] [Related]
18. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade. Parmeland L; Gazon M; Guerin C; Argaud L; Lehot JJ; Bastien O; Allaouchiche B; Michallet M; Picot S; Bienvenu AL; Med Mycol; 2013 Jan; 51(1):33-7. PubMed ID: 22680978 [TBL] [Abstract][Full Text] [Related]
19. Identification and antifungal susceptibility of Candida isolated from intensive care unit patients. Zer Y; Balci I; Meriç G New Microbiol; 2002 Oct; 25(4):489-94. PubMed ID: 12437230 [TBL] [Abstract][Full Text] [Related]
20. [Yeast infections: causative agents and their antifungal resistance in hospitalized pediatric patients and HIV-positive adults]. Rodero L; Boutureira M; Demkura H; Burkett A; Fernández C; Losso M; Jáuregui Rueda H; Monticelli A; Vitale R; Canteros C; Hochenfellner F; Vivot W; Davel G Rev Argent Microbiol; 1997; 29(1):7-15. PubMed ID: 9229726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]